← Leaderboards
Rick Hawkins
Mu Therapeutics, Inc.
$750,726
Attributed
$1,501,451
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–20$2M$1.5M$1M$500K$0
'18
'19
'20
Funding mix
By agency
NIH$1,501,451 · 1
By mechanism
R44$1,501,451 · 1
Top collaborators
- Wolfgang Sadee3 shared
Others in their field
Other Emerging Leaders on “Adverse Effects”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kristin Aillon · Midwest Research Institute$23,644,534
- Abraham Aizer Brody · New York University School Of Medicine$21,887,280
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
Research focus
Adverse EffectsAffectAnimal ModelAreaBehaviorBiological AvailabilityBiotechnologyBirthBirth WeightBloodBlood - Brain Barrier AnatomyBlood CirculationBrainBuprenorphineCaviaClinicCostCountryDosageDoseDrug KineticsEffective TherapyEmergency CareAdult